Naloxone
ID: 9594CS25Q0020Type: Solicitation
Overview

Buyer

COURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES AND OFFENDER SUPERVISION AGENCYCOURT SERVICES OFFENDER SUPV AGCYWASHINGTON, DC, 20004, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/afba69212f87409ab6361e814d2ebe1e/view
Timeline
    Description

    The Court Services and Offender Supervision Agency (CSOSA) is seeking proposals for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray, as outlined in their solicitation. This procurement aims to ensure the availability of this critical medication, which is essential for reversing opioid overdoses, thereby supporting public health and safety initiatives. The contract will be awarded under a firm-fixed price purchase order, with a submission deadline for quotations set for January 7, 2025. Interested vendors can direct inquiries to Matthew Collins at matthew.collins@csosa.gov or by phone at 202-369-7635 for further details on compliance and submission requirements.

    Point(s) of Contact
    Matthew Collins
    (202) 369-7635
    matthew.collins@csosa.gov
    Files
    Title
    Posted
    9594CS25Q0020 AMD 0001.pdf
    This document is Amendment 0001 to Solicitation 9594CS25Q0020 issued by the Court Services and Offender Supervision Agency regarding the procurement of Naloxone. The amendment outlines the acknowledgment requirements for any proposals, which must be communicated via specific methods prior to the deadline. It details the necessary contractor information to be included in submissions, replacing section L.1.2, which now specifies required details such as the contractor's contact information, Tax Identification Number, Unique Entity Identification, Cage Code, and a validity statement for the quotation. Additionally, a new section L.1.3 mandates information about the manufacturer of the quoted product. The amendment emphasizes that acknowledgment of receipt must be submitted with proposals to avoid rejection due to noncompliance. Overall, this document aims to clarify submission requirements and ensure compliance in the procurement process.
    Attachment J-1 FAR 52.212-3 Offeror Reps & Certs.docx
    The document outlines the Offeror Representations and Certifications required for federal solicitations, specifically focusing on commercial products and services. It details the criteria for small businesses, including those owned by economically disadvantaged women and service-disabled veterans, alongside requirements for various certifications, such as compliance with the Buy American Act and prohibitions on the use of certain telecommunications and technologies. The sections emphasize the necessity for offerors to confirm their business status, confirm integrity regarding federal contracts, disclose tax liabilities, report any previous contracts, and observe restrictions related to operations in Sudan and dealings with Iran. Overall, the document serves as a comprehensive guide for prospective contractors to ensure compliance with federal regulations and eligibility for government contracts while maintaining transparency and ethical business practices. The structured format allows offerors to indicate their compliance with specific requirements clearly, ensuring a thorough understanding of obligations under the given solicitation.
    Solicitation 9594CS25Q0020.pdf
    The document outlines a federal solicitation for the procurement of 450 packages of Naloxone 2 Dose Nasal Spray by the Court Services and Offender Supervision Agency (CSOSA). It specifies the required specifications, delivery timelines, and the contractual agreement structure, categorized under a firm-fixed price purchase order. The primary NAICS code for this contract is 325412, indicating it involves pharmaceutical preparation manufacturing, with a small business size standard of 1,300 employees. Key points include the requirement for vendors to submit their quotations by January 7, 2025, and details about the invoice processing via the Department of Treasury's Invoice Processing Platform. The solicitation emphasizes compliance with various federal regulations and clauses surrounding contractor conduct, payment processing, and delivery expectations, ensuring the procurement services align with government standards. The document is structured into sections addressing requisition details, supplies, specifications, delivery instructions, and administrative requirements, guiding potential contractors through the bidding process while ensuring adherence to government procurement policies.
    Lifecycle
    Title
    Type
    Naloxone
    Currently viewing
    Solicitation
    Similar Opportunities
    Sexual Offender Assessment &Treatment Services for Justice Involved Offenders
    Active
    Court Services And Offender Supervision Agency
    The Court Services and Offender Supervision Agency (CSOSA) is soliciting proposals for Sexual Offender Assessment and Treatment Services aimed at justice-involved offenders mandated by the courts. The procurement seeks comprehensive treatment and assessment services, including individual and group therapy, polygraph testing, and the development of individualized treatment plans to reduce recidivism among offenders. This initiative is critical for enhancing public safety and ensuring effective management of sexually offending behaviors, aligning with statutory requirements for offender rehabilitation. Interested vendors, particularly small businesses, must submit their quotes by February 5, 2025, and can direct inquiries to Mathew Collins at mathew.collins@csosa.gov or by phone at 202-369-7635.
    Safety Station Program
    Active
    Justice, Department Of
    The Department of Justice, specifically the Executive Office for Immigration Review (EOIR), is seeking proposals for the Safety Station Program, aimed at enhancing emergency preparedness across approximately 60 locations. The contractor will be responsible for providing and installing safety stations equipped with essential medical supplies, including FDA-approved AEDs, opioid reversal agents, and hemorrhagic control kits, along with staff training and ongoing maintenance to ensure compliance with safety regulations. This initiative underscores the government's commitment to public safety and effective emergency response within EOIR facilities. Proposals must be submitted by January 3, 2025, with the contract set to begin on January 6, 2025, and extend through January 5, 2030, with a total potential duration of 66 months. Interested parties can contact Andrew Byrnes at andrew.byrnes@usdoj.gov or 703-605-1739 for further information.
    DEA National Community Outreach and Prevention Engagement
    Active
    Justice, Department Of
    The Department of Justice, through the Drug Enforcement Administration (DEA), is preparing to solicit a five-year service contract for the National Community Outreach and Prevention Engagement (NCOE) initiative, aimed at addressing substance misuse across its 23 field divisions. This initiative focuses on fostering community coalitions and bridging public safety and health initiatives by employing evidence-based strategies for outreach, particularly targeting youth, schools, workplaces, and community engagement to combat various drug threats. The contractor will be responsible for organizing community stakeholder meetings, executing family and teen summits, and providing capacity-building training for local coalitions, along with delivering customizable training on substance misuse prevention and reporting on outreach effectiveness. Interested vendors should contact Charles Ivy at charles.d.ivy@dea.gov for further information and are encouraged to register with the System for Award Management (SAM.gov) to participate in this full and open competition, which will be structured as a firm fixed price contract.
    FY25 Bulk Pharma Buy (Materiel)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (ASPR), is seeking information from vendors regarding the procurement of pharmaceuticals for the Strategic National Stockpile (SNS) under the FY25 Bulk Pharma Buy initiative. The RFI aims to gather details on vendors' capabilities to supply FDA-approved pharmaceuticals, including Amoxicillin, Ciprofloxacin, and Clindamycin, which are critical for public health emergencies. This procurement is vital for ensuring rapid access to life-saving medical supplies during biological, chemical, and radiological threats, as well as natural disasters. Interested vendors must submit their responses electronically by January 8, 2025, and can direct inquiries to Terri Reed at terri.reed@hhs.gov.
    6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Fexofenadine HCL 60MG (500CT) for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). Vendors are required to submit detailed quotes that include a signed SF1449 solicitation cover page, a completed pricing schedule, a valid wholesale distributor license, and OEM authorization for over-the-counter products, ensuring compliance with the Buy American Act and other regulatory standards. This pharmaceutical product is critical for treating allergies and must meet stringent quality and safety requirements, including a minimum shelf life of one year upon delivery. Proposals are due by January 10, 2025, at 3:00 PM CT, and interested vendors can contact Contract Specialist Jennifer D Coleman at jennifer.coleman4@va.gov for further information.
    Bulk Pharma Group B
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the procurement of a range of FDA-approved pharmaceuticals as part of the Bulk Pharma Group B initiative. The contract will require the delivery of specific injectable medications, including Acyclovir Sodium, Doxycycline, Levophed, Meropenem, Sodium Chloride, and sterile water, with quantities detailed in the attached Request for Proposal (RFP). This procurement is critical for maintaining the Strategic National Stockpile, ensuring a reliable supply of essential pharmaceuticals for disaster preparedness and response efforts. Interested vendors must submit their proposals by the specified deadline, and inquiries can be directed to primary contact Terri Reed at terri.reed@hhs.gov or secondary contact Kimberly Golden at kimberly.golden1@hhs.gov.
    Ondansetron 4MG and 8MG
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ondansetron. This contract will establish a national supply source to provide Ondansetron HCL 4 and 8MG Tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The projected solicitation date is March of 2023.
    6505--Nadolol Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0014 concerning the procurement of Nadolol Tablets. This procurement aims to secure an uninterrupted supply of Nadolol Tablets for various federal health entities, including the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service, with a contract period of one year and four optional one-year extensions. The estimated annual requirements include approximately 7,753 bottles of 20MG, 6,085 bottles of 40MG, and 1,566 bottles of 80MG tablets, all of which must feature unique labeling (NDC number) as specified. The solicitation is expected to be released electronically on or around January 10, 2025, with responses due by January 27, 2025. Interested suppliers can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov.
    6505--765-25-1-021-0009 -Hines CMOP ACAMPROSATE -(VA-25-00012693)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Acamprosate Calcium 333mg, specifically for the Hines Consolidated Mail Outpatient Pharmacy (CMOP). This solicitation, identified by requisition number 36C77025Q0022, requires vendors to comply with federal regulations, including adherence to the Buy American Act, and mandates that all products have a minimum expiration date of one year upon delivery. The procurement is critical for ensuring reliable access to essential pharmaceuticals for veterans, emphasizing quality assurance and regulatory compliance throughout the process. Interested vendors must submit their quotes by January 10, 2025, at 3:00 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov or by phone at 913-758-9934.
    Second Chance Act Goods and Services Pre-Solicitation Notice
    Active
    Administrative Office Of The Us Courts
    Presolicitation notice: ADMINISTRATIVE OFFICE OF THE US COURTS is seeking goods and services related to Outpatient Mental Health and Substance Abuse Centers. The federal Judiciary intends to procure treatment services and/or Second Chance Act goods and services for federal defendants and persons under supervision using Blanket Purchase Agreements. The services may include urine collection, counseling, physical examinations, detoxification, residential treatment, and transportation. The goods and services may include cognitive behavioral therapy, child-care, medical services, computer hardware/software, identification, transportation, transitional housing, domestic violence intervention, and job training. The specific services and requirements will be identified in the solicitation for Blanket Purchase Agreements.